Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03057041 · ClinicalTrials.gov registry record · NA
Intranasal Fentanyl for Pain Control During First-Trimester Uterine Aspiration
A NA study, sponsored by University of Hawaii.
- Completed
- Registry status
- NA
- Development phase
- 107
- Enrollment target
NCT03057041 is a NA study that has completed, run by University of Hawaii. The registered enrollment target is 107 participants.
The verdict
NCT03057041, a NA study, has completed, sponsored by University of Hawaii.
- COMPLETED
- Registry status
- NA
- Development phase
- 107 participants
- Enrollment target
Study Summary
Intranasal fentanyl has been found to be safe and effective in the reduction of pain among pediatric and adult populations. The investigators hypothesize that patients who receive 100 mcg of intranasal fentanyl for pain control before first-trimester uterine aspiration will report lower pain scores than those who receive placebo. The investigators will test this hypothesis using a randomized, double-blind, placebo-controlled trial comparing pain reported during uterine aspiration between patients who receive either intranasal fentanyl or intranasal saline prior to the procedure.
Interventions
- DRUG placebo
- DRUG Fentanyl
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 107 participants |
| Start Date | 2017-03-23 |
| Est. Completion | 2018-05-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03057041
The ClinicalTrials.gov registry entry for NCT03057041 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 107 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Hawaii, which has 77 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT03057041 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03057041 about?
NCT03057041 is a clinical study titled "Intranasal Fentanyl for Pain Control During First-Trimester Uterine Aspiration". Intranasal fentanyl has been found to be safe and effective in the reduction of pain among pediatric and adult populations. The investigators hypothesize that patients who receive 100 mcg of intranasal fentanyl for pain control before first-trimester uterine aspiration will report lower pain scores ...
What is the current status of trial NCT03057041?
This trial is currently completed. It is a NA study. The enrollment target is 107 participants. The study started on 2017-03-23. Estimated completion is 2018-05-30.
What interventions are being tested in trial NCT03057041?
The interventions under investigation include: placebo (DRUG), Fentanyl (DRUG).
Who is sponsoring clinical trial NCT03057041?
This trial is sponsored by University of Hawaii, which has 77 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.